New AI system can monitor your sleep with radio waves

Agencies
August 8, 2017

Boston, Aug 8: Scientists have developed a new artificial intelligence system that can monitor a person's sleep using ambient radio waves, without sensors attached to the body.

The device analyses the radio signals around the person and translates those measurements into sleep stages - light, deep, or rapid eye movement (REM).

Researchers at Massachusetts Institute of Technology (MIT) and Massachusetts General Hospital in the US have devised a new way to monitor sleep stages without sensors attached to the body.

"Imagine if your Wi-Fi router knows when you are dreaming, and can monitor whether you are having enough deep sleep, which is necessary for memory consolidation," said Dina Katabi, professor at MIT, who led the study.

"Our vision is developing health sensors that will disappear into the background and capture physiological signals and important health metrics, without asking the user to change her behaviour in any way," Katabi said.

Researchers had previously developed radio-based sensors that enable them to remotely measure vital signs and behaviours that can be indicators of health.

These sensors consist of a wireless device, about the size of a laptop computer, that emits low-power radio frequency (RF) signals.

As the radio waves reflect off of the body, any slight movement of the body alters the frequency of the reflected waves.

Analysing those waves can reveal vital signs such as pulse and breathing rate. "It's a smart Wi-Fi-like box that sits in the home and analyses these reflections and discovers all of these changes in the body, through a signature that the body leaves on the RF signal," Katabi said.

The approach could be useful for monitoring sleep, which is currently done while patients spend the night in a sleep lab hooked up to monitors such as electroencephalography (EEG) machines.

"We have this technology that, if we can make it work, can move us from a world where we do sleep studies once every few months in the sleep lab to continuous sleep studies in the home," said Mingmin Zhao, an MIT graduate student.

To achieve that, researchers had to come up with a way to translate their measurements of pulse, breathing rate, and movement into sleep stages.

Recent advances in artificial intelligence have made it possible to train computer algorithms known as deep neural networks to extract and analyse information from complex datasets, such as the radio signals obtained from the researchers' sensor.

However, these signals have a great deal of information that is irrelevant to sleep and can be confusing to existing algorithms.

The MIT researchers had to come up with a new AI algorithm based on deep neural networks, which eliminates the irrelevant information.

Using this approach in tests of 25 healthy volunteers, the researchers found that their technique was about 80 per cent accurate, which is comparable to the accuracy of ratings determined by sleep specialists based on EEG measurements.

"Our device allows you not only to remove all of these sensors that you put on the person, and make it a much better experience that can be done at home, it also makes the job of the doctor and the sleep technologist much easier," Katabi said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 27,2020

New Delhi, Mar 27: The Centre has restricted sale and distribution of "hydroxychloroquine" declaring it as an essential drug to treat the COVID-19 patients and meet the requirements of emergency arising due to the pandemic.

The Ministry of Health and Family Welfare on Thursday made the announcement making it clear that the order "shall come into force on the date of its publication in the official Gazette".

In the order, the government declared that the Central government is "satisfied that the drug hydroxychloroquine is essential to meet the requirements of emergency arising due to pandemic COVID-19 and in the public interest, it is necessary and expedient to regulate and restrict the sale and distribution of the drug 'hydroxychloroquine' and preparation based thereon for preventing their misuse".

"Now, therefore, in exercise of the powers conferred by Section 26B of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central government hereby directs that sale by retail of any preparation containing the drug Hydroxychloroquine shall be in accordance with the conditions for sale of drugs specified in Schedule H1 to the Drugs and Cosmetics Rules, 1945."

The order came at a time when the novel coronavirus claimed 16 lives and infected over 600 people across India.

The announcement regarding ban of sale and distribution of the drug was made by the government earlier but it issued an official Gazette notification on Thursday signalling that hydroxychloroquine -- an anti-Malaria drug -- will work as a medicine for treating coronavirus infected patients as well.

Recently, the national task force for COVID-19 constituted by Indian Council for Medical Research (ICMR) has recommended hydroxy-chloroquine as a preventive medication.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 23,2020

Los Angeles, Feb 23: According to researchers, if administered quickly, a common medication that reduces bleeding could be a treatment for bleeding stroke.

The Spot Sign and Tranexamic Acid on Preventing ICH Growth - Australasia Trial (STOP-AUST) was a multicenter, prospective, randomized, double-blind, placebo-controlled, phase 2 clinical trial using the antifibrinolytic agent tranexamic acid in people with intracerebral hemorrhage (ICH).

ICH is a severe form of acute stroke with few treatment options.

Tranexamic acid is currently used to treat or prevent excessive blood loss from trauma, surgery, tooth removal, nosebleeds and heavy menstruation. For this study, one hundred patients with active brain bleeding were given either intravenous tranexamic acid or placebo within 4.5 hours of symptom onset.

Researchers analyzed brain CT scans taken during the 24-hour period after treatment with tranexamic acid or placebo.

Researchers found a trend towards reduced hemorrhage expansion in the group treated with tranexamic acid, especially in those treated within 3 hours of the brain bleed. However, this trend was not statistically significant. The finding was consistent with previous research using the medication.

"Further trials using tranexamic acid are ongoing and focusing on ultra-early treatment - within 2 hours. 

This is where the greatest opportunity for intervention appears to be. Tranexamic acid is inexpensive, safe and widely available. Our results and others provide great impetus for further, focused research using this treatment," Nawaf Yassi said.

Larger trials focused on patient outcomes are required for this therapy to enter routine clinical practice.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
April 17,2020

Washington DC, Apr 17: In recent research, scientists have linked the emotional, social and psychiatric problems in children and adolescents with higher levels of genetic vulnerability for adult depression. The study implies that the genetics passed from parents may be linked with psychiatric problems in children and adolescents and may also leading to depression in adults.

University of Queensland scientists made the finding while analysing the genetic data of more than 42,000 children and adolescents from seven cohorts across Finland, the Netherlands, Norway, Sweden and the UK.

Professor Christel Middeldorp said that researchers have also found a link with a higher genetic vulnerability for insomnia, neuroticism and body mass index.

"By contrast, study participants with higher genetic scores for educational attainment and emotional well-being were found to have reduced childhood problems," Professor Middeldorp said.

"We calculated a person's level of genetic vulnerability by adding up the number of risk genes they had for a specific disorder or trait and then made adjustments based on the level of importance of each gene We found the relationship was mostly similar across ages," Middeldorp added.

The results indicate there are shared genetic factors that affect a range of psychiatric and related traits across a person's lifespan.

Middeldorp said that around 50 per cent of children and adolescents with psychiatric problems, such as attention deficit hyperactivity disorder (ADHD), continue to experience mental disorders as adults, and are at risk of disengaging with their school community among other social and emotional problems.

"Our findings are important as they suggest this continuity between childhood and adult traits is partly explained by genetic risk," the Professor said.

"Individuals at risk of being affected should be the focus of attention and targeted treatment," Middeldorp continued.

"Although the genetic vulnerability is not accurate enough at this stage to make individual predictions about how a person's symptoms will develop over time, it may become so in the future, in combination with other risk factors. And, this may support precision medicine by providing targeted treatments to children at the highest risk of persistent emotional and social problems," Middeldorp added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.